Growth Metrics

Fulgent Genetics (FLGT) Shares Outstanding (Diluted Average) (2016 - 2025)

Fulgent Genetics' Shares Outstanding (Diluted Average) history spans 10 years, with the latest figure at $30.7 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 2.04% year-over-year to $30.7 million; the TTM value through Sep 2025 reached $30.7 million, up 2.04%, while the annual FY2022 figure was $31.0 million, 0.04% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $30.7 million at Fulgent Genetics, up from $30.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $31.2 million in Q1 2022 and bottomed at $29.5 million in Q1 2023.
  • The 5-year median for Shares Outstanding (Diluted Average) is $30.8 million (2021), against an average of $30.5 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) soared 42.68% in 2021 before it dropped 5.45% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $31.0 million in 2021, then decreased by 0.04% to $31.0 million in 2022, then fell by 3.79% to $29.8 million in 2023, then grew by 1.03% to $30.1 million in 2024, then rose by 2.04% to $30.7 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Shares Outstanding (Diluted Average) are $30.7 million (Q3 2025), $30.5 million (Q2 2025), and $30.8 million (Q1 2025).